Original Literature | Model OverView |
---|---|
Publication
Title
Toll-like receptors and RNA helicases: two parallel ways to trigger antiviralresponses.
Affiliation
Department of Biochemistry, University of Lausanne, BIL Biomedical ResearchCenter, Chemin des Boveresses 155, CH-1066 Epalinges, Switzerland.
Abstract
The early detection by the host of invading microorganisms, including viruses,depends on a limited number of specific receptors that recognizepathogen-associated molecular patterns (PAMPs). A few of these PAMPs, includingssRNA and dsRNA, are recognized by Toll-like receptors (TLR)-7/8 and TLR3,respectively. Activation of an antiviral TLR-dependent signaling cascade leadsto the activation of the key transcription factors IRF and NF-kappaB, whichpromote antiviral responses through induction of specific genes. Recently, asecond system has been described, which relies on the cytoplasmic recognition ofdsRNA by RNA helicases such as RIG-I. In this review, we discuss the mechanisticaspects of these important arms of the host innate response to dsRNA and a fewviral strategies utilized to counteract them.
PMID
16762830
|
Entity
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m22
10
infinite
0
TRANSPATH | MO000000058 |
--
RIP1k63{ub}
--
MO000000065
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m20
10
infinite
0
InterPro | IPR000198 |
TRANSPATH | MO000000065 |
--
IKK-alpha
--
MO000000210
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m181
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000210 |
--
IKK-beta
--
MO000000211
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m182
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000211 |
--
IRF-3
--
MO000007694
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m977
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007694 |
--
IRF-7
--
MO000007702
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m980
10
infinite
0
TRANSPATH | MO000007702 |
--
A20
--
MO000016591
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1585
10
infinite
0
InterPro | IPR002653 |
TRANSPATH | MO000016591 |
--
IKK-i
--
MO000016608
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1599
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000016608 |
--
TRAF1
--
MO000016962
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1871
10
infinite
0
InterPro | IPR002083 |
TRANSPATH | MO000016962 |
--
TBK1
--
MO000019331
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3902
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000019331 |
--
dsRNA
--
MO000022224
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m119368
10
infinite
0
TRANSPATH | MO000022224 |
--
TRIF
--
MO000041125
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m18998
10
infinite
0
TRANSPATH | MO000041125 |
--
MAVS
--
MO000094908
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m68199
10
infinite
0
TRANSPATH | MO000094908 |
--
IFIH1
--
MO000103999
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m76904
10
infinite
0
TRANSPATH | MO000103999 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
DDX58:dsRNA:MAVS:TBK1:IKK-i
--
e10
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m10
0
infinite
0
--
--
e11
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeLumen
--
--
--
csml-variable:Double
m11
0
infinite
0
--
dsRNA:TLR3
--
e12
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m12
0
infinite
0
--
csml-variable:Double
m13
0
infinite
0
--
TLR7:ssRNA
--
e14
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m14
0
infinite
0
--
TLR8:ssRNA
--
e15
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m15
0
infinite
0
--
csml-variable:Double
m16
0
infinite
0
--
TLR9:CpG motif
--
e17
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
--
csml-variable:Double
m17
0
infinite
0
--
dsRNA:TLR3:TRIF
--
e18
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m18
0
infinite
0
--
dsRNA:TLR3:TRIF:TRAF6
--
e19
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
dsRNA:TLR3:TRIF:TRAF6:RIP1
--
e20
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m21
0
infinite
0
--
NF-kappaB{active}
--
e21
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m23
10
infinite
0
TRANSPATH | MO000000058 |
--
dsRNA:TLR3:TRIF:TRAF6:RIP3
--
e22
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m24
0
infinite
0
--
TLR7:ssRNA:MyD88
--
e23
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m25
0
infinite
0
--
dsRNA:TLR3:TRIF:TRAF3
--
e24
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m26
0
infinite
0
--
TLR7:ssRNA:MYD88:IRAK1:IRAK-4
--
e25
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m27
0
infinite
0
--
dsRNA:TLR3:TRIF:TRAF3:TBK1:IKK-i
--
e26
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m28
0
infinite
0
--
IRF-3{active}
--
e27
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m29
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007694 |
--
TLR7:ssRNA:MYD88:IRAK1:IRAK-4:TRAF3:TRAF6
--
e28
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m30
0
infinite
0
--
DDx58:dsRNA
--
e29
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m31
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
DDX58:dsRNA:MAVS
--
e30
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m32
0
infinite
0
--
A46R
--
e31
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m33
0
infinite
0
--
TLR7:ssRNA:MyD88:A46R
--
e32
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m34
0
infinite
0
--
A46R:TIRAP
--
e33
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m35
0
infinite
0
--
A46R:TRAM
--
e34
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m36
0
infinite
0
--
DDX58:dsRNA:MAVS:IKK-alpha:IKK-beta
--
e35
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m37
0
infinite
0
--
TLR7:ssRNA:MYD88:IRAK1:IRAK-4:TRAF3:TRAF6:TBK1:IKK-i
--
e36
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m38
0
infinite
0
--
TLR7:ssRNA:MYD88:IRAK1:IRAK-4:TRAF3:TRAF6:IKK-alpha:IKK-beta
--
e37
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m39
0
infinite
0
--
dsRNA:TLR3:TRIF:TRAF6:RIP1:IKK-alpha:IKK-beta
--
e38
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m40
0
infinite
0
--
IFIH1:dsRNA
--
e39
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m41
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
IFIH1:dsRNA:MAVS
--
e40
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m42
0
infinite
0
--
IFIH1:dsRNA:MAVS:TBK1:IKK-i
--
e41
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m43
0
infinite
0
--
IFIH1:dsRNA:MAVS:IKK-alpha:IKK-beta
--
e42
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m44
0
infinite
0
--
Lgp2
--
e43
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m45
0
infinite
0
--
Lgp2:dsRNA
--
e44
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m46
0
infinite
0
--
protein remnants
--
e45
cso30:c:EntityBiological
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m47
0
infinite
0
--
SIKE
--
e46
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m48
0
infinite
0
--
SIKE:IRF-3
--
e47
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m49
0
infinite
0
--
IRF-7{active}
--
e48
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m63
10
infinite
0
TRANSPATH | MO000007702 |
--
SIKE:IRF-7
--
e49
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m64
0
infinite
0
--
--
e5
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Endosome
--
--
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
--
e6
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeMembrane
--
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
SIKE:TBK1
--
e63
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m65
0
infinite
0
--
SIKE:IKK-i
--
e64
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m66
0
infinite
0
--
V-proteins
--
e65
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m67
0
infinite
0
--
IFIH1:V-proteins
--
e66
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m68
0
infinite
0
--
Type I IFN
--
e67
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m69
0
infinite
0
--
Type I IFN
--
e68
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m70
0
infinite
0
--
PKR:dsRNA
--
e69
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m71
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
eIF2{alpha)
--
e70
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m72
0
infinite
0
--
eIF2{alpha){active}
--
e71
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m73
0
infinite
0
--
2'-5'oligoadenylate synthetase
--
e72
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m74
0
infinite
0
--
2'-5' oligoadenylate synthetase:dsRNA
--
e73
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m75
0
infinite
0
--
endoribonuclease RNase L
--
e74
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m76
0
infinite
0
--
endoribonuclease RNase L{active}
--
e75
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m77
0
infinite
0
--
NS3-4A
--
e78
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m80
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m119368*m3965*0.1
nodelay
--
0
PMID: 16762830,11607032,14976261,14976262,11130078,15034168 Interestingly, the latter TLRs share the ability of nucleic acid recognition, detecting dsRNA (TLR3), ssRNA (TLR7 in mice, TLR8 in humans), and nonmethylated CpG DNA motifs (TLR9)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c29 : 1
stoichiometry:c30 : 1
stoichiometry:c31 : 1
m14*m1572*0.1
nodelay
--
0
PMID:16762830 To promote type-I IFN production in pDCs, TLR7 most probably utilizes MyD88, IL-1R associated kinase (IRAK)-1, TRAF3 and TRAF6
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c32 : 1
stoichiometry:c33 : 1
stoichiometry:c34 : 1
m1872*m18*0.1
nodelay
--
0
PMID: 16763830,16306937,16306936 Interestingly, two recent studies have used TRAF3-deficient cells to reveal this molecule as an essential intermediate transmitting antiviral responses, partly through binding to Trif and the kinases TBK1 and IKK-i
p11
p12
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c36 : 1
stoichiometry:c35 : 1
stoichiometry:c41 : 1
stoichiometry:c37 : 1
m26*m1599*m3902*0.1
nodelay
--
0
PMID: 16763830,16306937,16306936 Interestingly, two recent studies have used TRAF3-deficient cells to reveal this molecule as an essential intermediate transmitting antiviral responses, partly through binding to Trif and the kinases TBK1 and IKK-i
p13
p13
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c39 : 1
stoichiometry:c62 : 1
stoichiometry:c133 : 1
stoichiometry:c40 : 1
m28*m977*0.1
nodelay
--
0
PMID: 16762830 To activate IRF, Trif recruits TBK1 and possibly TRAF3 PMID: 16762830,10920188,15767367 One of its proteins, A46R, is the only reported viral protein containing a TIR domain. Through the use of this domain, Vaccinia virus can inhibit Trif-mediated IRF3 activation, thereby preventing one branch of TLR3 signaling. PMID: 16762830 Another molecule, TRAF1, which is a unique NF-¦ÊB-inducible member of the TRAF family that lacks an N-terminal RING finger, also inhibits Trif signaling to both IRF3 and NF-¦ÊB.
p14
p14
cso30:i:ME_Binding
cso30:i:CC_EndosomeLumen
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c42 : 1
stoichiometry:c43 : 1
stoichiometry:c44 : 1
stoichiometry:c45 : 1
m25*m184*m17258*0.1
nodelay
--
0
PMID: 16762830, MyD88 recruits IRAKs through DD-DD interactions, and also TRAF3 and TRAF6, to activate IRF and NF-kB. PMID:16762830 To promote type-I IFN production in pDCs, TLR7 most probably utilizes MyD88, IL-1R associated kinase (IRAK)-1, TRAF3 and TRAF6
p14
p15
cso30:i:ME_Binding
cso30:i:CC_EndosomeLumen
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c47 : 1
stoichiometry:c48 : 1
stoichiometry:c49 : 1
m27*m1872*m183*0.1
nodelay
--
0
PMID: 16762830, MyD88 recruits IRAKs through DD-DD interactions, and also TRAF3 and TRAF6, to activate IRF and NF-kB. PMID:16762830 To promote type-I IFN production in pDCs, TLR7 most probably utilizes MyD88, IL-1R associated kinase (IRAK)-1, TRAF3 and TRAF6
p16
p16
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c88 : 1
stoichiometry:c52 : 1
m977*m38*0.1
nodelay
--
0
PMID: 16762830, MyD88 recruits IRAKs through DD-DD interactions, and also TRAF3 and TRAF6, to activate IRF and NF-kB. PMID:16762830 To promote type-I IFN production in pDCs, TLR7 most probably utilizes MyD88, IL-1R associated kinase (IRAK)-1, TRAF3 and TRAF6 PMID: 16762830 Figure 1, Table 1
p16
p17
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c54 : 1
stoichiometry:c92 : 1
stoichiometry:c55 : 1
m22*m39*0.1
nodelay
--
0
PMID: 16762830, MyD88 recruits IRAKs through DD-DD interactions, and also TRAF3 and TRAF6, to activate IRF and NF-kB. PMID:16762830 To promote type-I IFN production in pDCs, TLR7 most probably utilizes MyD88, IL-1R associated kinase (IRAK)-1, TRAF3 and TRAF6 PMID: 16762830 Figure 1, Table 1
p18
p18
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c57 : 1
stoichiometry:c58 : 1
m41844*m119368*0.1
nodelay
--
0
PMID: 16762830,15208624 The recent characterization of retinoic acid inducible gene-I (RIG-I) as a cytoplasmic dsRNA receptor has defined a novel antiviral pathway and has also permitted a clearer comprehension of signals emanating from TLR-dependent and -independent antiviral mechanisms
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c59 : 1
stoichiometry:c60 : 1
stoichiometry:c61 : 1
m31*m68199*0.1
nodelay
--
0
PMID: 16762830,16127453,16177806,16125763 To trigger antiviral responses, RIG-I recruits the adaptor CARD adaptor inducing IFN-b (Cardif, also called MAVS, IPS-1, and VISA) in a CARD-CARD-dependent manner
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c8 : 1
m13*m19940*0.1
nodelay
--
0
PMID: 16762830,11607032,14976261,14976262,11130078,15034168 Interestingly, the latter TLRs share the ability of nucleic acid recognition, detecting dsRNA (TLR3), ssRNA (TLR7 in mice, TLR8 in humans), and nonmethylated CpG DNA motifs (TLR9)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c63 : 1
stoichiometry:c64 : 1
stoichiometry:c65 : 1
m33*m25*0.1
nodelay
--
0
PMID: 16762830,15767367 Interestingly, A46R may have a broader spectrum of effects, because it also binds three other TIR adaptors, MyD88, TIRAP (Mal), and TRAM, but not SARM, in these contexts, interfering with NF-¦ÊB and MAP kinase activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c66 : 1
stoichiometry:c67 : 1
stoichiometry:c68 : 1
m6810*m33*0.1
nodelay
--
0
PMID: 16762830,15767367 Interestingly, A46R may have a broader spectrum of effects, because it also binds three other TIR adaptors, MyD88, TIRAP (Mal), and TRAM, but not SARM, in these contexts, interfering with NF-¦ÊB and MAP kinase activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c69 : 1
stoichiometry:c70 : 1
stoichiometry:c71 : 1
m33*m19005*0.1
nodelay
--
0
PMID: 16762830,15767367 Interestingly, A46R may have a broader spectrum of effects, because it also binds three other TIR adaptors, MyD88, TIRAP (Mal), and TRAM, but not SARM, in these contexts, interfering with NF-¦ÊB and MAP kinase activation
p23
p23
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c73 : 1
stoichiometry:c74 : 1
stoichiometry:c188 : 1
stoichiometry:c75 : 1
m3902*m1599*m32*0.1
nodelay
--
0
PMID: 16762830 Mitochondrial bound Cardif in turn recruits appropriate IKKs to activate NF-kB and IRF. PMID: 16762830 After the CARD-CARD-dependent interaction with RIG-I, Cardif recruits crucial molecules that transmit downstream signaling resulting in NF-¦ÊB and IRF activation PMID: 16762830,15710891,15767399,15710892 Whereas the adaptor Trif is an NS3-4A cleavage target in the TLR3 pathway,, NS3-4A disruption of RIG-I signaling occurs in a step between RIG-I and IKKvar epsilon, because the latter kinase rescues NS3-4A-mediated blockage
p24
p24
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c77 : 1
stoichiometry:c128 : 1
stoichiometry:c78 : 1
m10*m977*0.1
nodelay
--
0
PMID: 16762830 Mitochondrial bound Cardif in turn recruits appropriate IKKs to activate NF-kB and IRF. PMID: 16762830 After the CARD-CARD-dependent interaction with RIG-I, Cardif recruits crucial molecules that transmit downstream signaling resulting in NF-¦ÊB and IRF activation PMID: 16762830,16306043 Indeed, the overexpression of A20 dose-dependently attenuates RIG-I-induced IRF and NF-¦ÊB activation
p23
p25
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c79 : 1
stoichiometry:c80 : 1
stoichiometry:c81 : 1
stoichiometry:c82 : 1
m181*m32*m182*0.1
nodelay
--
0
PMID: 16762830 Mitochondrial bound Cardif in turn recruits appropriate IKKs to activate NF-kB and IRF. PMID: 16762830 After the CARD-CARD-dependent interaction with RIG-I, Cardif recruits crucial molecules that transmit downstream signaling resulting in NF-¦ÊB and IRF activation
p24
p26
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c83 : 1
stoichiometry:c84 : 1
stoichiometry:c127 : 1
stoichiometry:c85 : 1
m37*m22*0.1
nodelay
--
0
PMID: 16762830 Mitochondrial bound Cardif in turn recruits appropriate IKKs to activate NF-kB and IRF. PMID: 16762830 After the CARD-CARD-dependent interaction with RIG-I, Cardif recruits crucial molecules that transmit downstream signaling resulting in NF-¦ÊB and IRF activation PMID: 16762830,16306043 Indeed, the overexpression of A20 dose-dependently attenuates RIG-I-induced IRF and NF-¦ÊB activation
p27
p27
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c86 : 1
stoichiometry:c87 : 1
m3902*m1599*0.1
nodelay
--
0
PMID: 16762830, MyD88 recruits IRAKs through DD-DD interactions, and also TRAF3 and TRAF6, to activate IRF and NF-kB. PMID:16762830 To promote type-I IFN production in pDCs, TLR7 most probably utilizes MyD88, IL-1R associated kinase (IRAK)-1, TRAF3 and TRAF6 PMID: 16762830 Figure 1, Table 1
p27
p28
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c89 : 1
stoichiometry:c90 : 1
stoichiometry:c91 : 1
m30*m181*m182*0.1
nodelay
--
0
PMID: 16762830, MyD88 recruits IRAKs through DD-DD interactions, and also TRAF3 and TRAF6, to activate IRF and NF-kB. PMID:16762830 To promote type-I IFN production in pDCs, TLR7 most probably utilizes MyD88, IL-1R associated kinase (IRAK)-1, TRAF3 and TRAF6 PMID: 16762830 Figure 1, Table 1
p29
p29
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c94 : 1
stoichiometry:c95 : 1
stoichiometry:c96 : 1
m21*m181*m182*0.1
nodelay
--
0
PMID: 16762830 Figure1, Table 1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c6 : 1
stoichiometry:c7 : 1
stoichiometry:c9 : 1
m19823*m13*0.1
nodelay
--
0
PMID: 16762830,11607032,14976261,14976262,11130078,15034168 Interestingly, the latter TLRs share the ability of nucleic acid recognition, detecting dsRNA (TLR3), ssRNA (TLR7 in mice, TLR8 in humans), and nonmethylated CpG DNA motifs (TLR9)
p30
p30
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c97 : 1
stoichiometry:c98 : 1
stoichiometry:c99 : 1
m76904*m119368*0.1
nodelay
--
0
PMID: 16762830 Upon dsRNA binding, RIG-I (and also MDA5) recruits the adaptor Cardif through a CARD-CARD interaction
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c100 : 1
stoichiometry:c101 : 1
stoichiometry:c192 : 1
m41*m68199*0.1
nodelay
--
0
PMID: 16762830 Upon dsRNA binding, RIG-I (and also MDA5) recruits the adaptor Cardif through a CARD-CARD interaction PMID: 16762830,16127453 Further, MDA5 may also transmit antiviral responses through Cardif,, suggesting that RIG-I- and MDA5-dependent signaling pathways converge at the adaptor level PMID: 16762830 Figure 1
p23
p32
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c103 : 1
stoichiometry:c104 : 1
stoichiometry:c105 : 1
stoichiometry:c106 : 1
m42*m3902*m1599*0.1
nodelay
--
0
PMID: 16762830 Mitochondrial bound Cardif in turn recruits appropriate IKKs to activate NF-kB and IRF.
p33
p33
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c107 : 1
stoichiometry:c108 : 1
stoichiometry:c109 : 1
m43*m977*0.1
nodelay
--
0
PMID: 16762830,15563593 Similar to RIG-I, overexpression of MDA5 leads to NF-¦ÊB and IRF activation
p23
p34
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c110 : 1
stoichiometry:c111 : 1
stoichiometry:c112 : 1
stoichiometry:c113 : 1
m42*m181*m182*0.1
nodelay
--
0
PMID: 16762830 Mitochondrial bound Cardif in turn recruits appropriate IKKs to activate NF-kB and IRF.
p33
p35
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c114 : 1
stoichiometry:c115 : 1
stoichiometry:c116 : 1
m44*m22*0.1
nodelay
--
0
PMID: 16762830,15563593 Similar to RIG-I, overexpression of MDA5 leads to NF-¦ÊB and IRF activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c117 : 1
stoichiometry:c118 : 1
stoichiometry:c119 : 1
m45*m119368*0.1
nodelay
--
0
PMID: 16762830,16210631,16116171 A third RIG-I-like RNA helicase, Lgp2, was recently demonstrated to bind dsRNA
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c124 : 1
stoichiometry:c126 : 1
m79*0.1
nodelay
--
0
PMID: 16762830,15258597 These activities therefore target RIP1 for proteasome-dependent degradation
p38
p38
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c120 : 1
stoichiometry:c121 : 1
stoichiometry:c123 : 1
stoichiometry:c122 : 1
m175*m22*m20*0.1
nodelay
--
0
PMID: 16762830,9529147 TNF-induced NF-¦ÊB activation relies on the DD kinase RIP1
p39
p39
cso30:i:ME_UnknownDegradation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c129 : 1
stoichiometry:c130 : 1
stoichiometry:c131 : 1
m1585*m18998*0.1
nodelay
--
0
PMID: 16762830,16306043,15474016 Further, A20 may also downregulate TLR3-dependent responses, possibly through targeting Trif for degradation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
stoichiometry:c12 : 1
m19828*m16*0.1
nodelay
--
0
PMID: 16762830,11607032,14976261,14976262,11130078,15034168 Interestingly, the latter TLRs share the ability of nucleic acid recognition, detecting dsRNA (TLR3), ssRNA (TLR7 in mice, TLR8 in humans), and nonmethylated CpG DNA motifs (TLR9)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c134 : 1
stoichiometry:c135 : 1
stoichiometry:c136 : 1
m48*m977*0.1
nodelay
--
0
PMID: 16762830 SIKE interacts with both IRF3/7 kinases, IKKvar epsilon, and TBK1 and most probably sequesters them away from IRF3 and the adaptor Trif (and maybe Cardif as well).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c137 : 1
stoichiometry:c138 : 1
stoichiometry:c139 : 1
m48*m980*0.1
nodelay
--
0
PMID: 16762830 SIKE interacts with both IRF3/7 kinases, IKKvar epsilon, and TBK1 and most probably sequesters them away from IRF3 and the adaptor Trif (and maybe Cardif as well).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c141 : 1
stoichiometry:c142 : 1
stoichiometry:c143 : 1
m48*m3902*0.1
nodelay
--
0
PMID: 16762830 SIKE interacts with both IRF3/7 kinases, IKKvar epsilon, and TBK1 and most probably sequesters them away from IRF3 and the adaptor Trif (and maybe Cardif as well).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c144 : 1
stoichiometry:c145 : 1
stoichiometry:c146 : 1
m48*m1599*0.1
nodelay
--
0
PMID: 16762830 SIKE interacts with both IRF3/7 kinases, IKKvar epsilon, and TBK1 and most probably sequesters them away from IRF3 and the adaptor Trif (and maybe Cardif as well).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c147 : 1
stoichiometry:c148 : 1
stoichiometry:c149 : 1
m76904*m67*0.1
nodelay
--
0
PMID: 16762830,15563593 The V proteins of different ssRNA paramyxoviruses, including SeV, have recently been reported to bind to and inhibit MDA5-dependent type-I IFN production
p45
p45
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c150 : 1
stoichiometry:c151 : 1
stoichiometry:c152 : 1
m28*m980*0.1
nodelay
--
0
PMID: 16762830,14517278,12539043,12471095 Trif signaling leads to IRF3 and IRF7 activation and type-I IFN production
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c153 : 1
stoichiometry:c156 : 1
stoichiometry:c167 : 1
stoichiometry:c157 : 1
m63*m69*0.1
nodelay
--
0
PMID: 16762830,14517278,12539043,12471095 Trif signaling leads to IRF3 and IRF7 activation and type-I IFN production PMID:16762830 To promote type-I IFN production in pDCs, TLR7 most probably utilizes MyD88, IL-1R associated kinase (IRAK)-1, TRAF3 and TRAF6 PMID: 16762830 Figure 1, Table 1 PMID: 16762830,15563593 The V proteins of different ssRNA paramyxoviruses, including SeV, have recently been reported to bind to and inhibit MDA5-dependent type-I IFN production
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c154 : 1
stoichiometry:c155 : 1
stoichiometry:c168 : 1
stoichiometry:c158 : 1
m29*m69*0.1
nodelay
--
0
PMID: 16762830,14517278,12539043,12471095 Trif signaling leads to IRF3 and IRF7 activation and type-I IFN production PMID:16762830 To promote type-I IFN production in pDCs, TLR7 most probably utilizes MyD88, IL-1R associated kinase (IRAK)-1, TRAF3 and TRAF6 PMID: 16762830 Figure 1, Table 1 PMID: 16762830,15563593 The V proteins of different ssRNA paramyxoviruses, including SeV, have recently been reported to bind to and inhibit MDA5-dependent type-I IFN production
p16
p48
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c159 : 1
stoichiometry:c160 : 1
stoichiometry:c161 : 1
m38*m980*0.1
nodelay
--
0
PMID: 16762830, MyD88 recruits IRAKs through DD-DD interactions, and also TRAF3 and TRAF6, to activate IRF and NF-kB. PMID:16762830 To promote type-I IFN production in pDCs, TLR7 most probably utilizes MyD88, IL-1R associated kinase (IRAK)-1, TRAF3 and TRAF6 PMID: 16762830 Figure 1, Table 1
p24
p49
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c162 : 1
stoichiometry:c140 : 1
stoichiometry:c163 : 1
m10*m980*0.1
nodelay
--
0
PMID: 16762830 Mitochondrial bound Cardif in turn recruits appropriate IKKs to activate NF-kB and IRF. PMID: 16762830 After the CARD-CARD-dependent interaction with RIG-I, Cardif recruits crucial molecules that transmit downstream signaling resulting in NF-¦ÊB and IRF activation PMID: 16762830,16306043 Indeed, the overexpression of A20 dose-dependently attenuates RIG-I-induced IRF and NF-¦ÊB activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c14 : 1
stoichiometry:c15 : 1
m12*m18998*0.1
nodelay
--
0
PMID: 16762830,12872135,12471095,12855817 Although most TLRs recruit MyD88 to transmit antimicrobial responses, the elucidation of TLR3 signaling arose from the finding that TLR3 recruits Trif, but no other TIR adaptor, to mediate antiviral responses
p33
p50
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c164 : 1
stoichiometry:c165 : 1
stoichiometry:c166 : 1
m43*m980*0.1
nodelay
--
0
PMID: 16762830,15563593 Similar to RIG-I, overexpression of MDA5 leads to NF-¦ÊB and IRF activation
p51
p51
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c169 : 1
stoichiometry:c170 : 1
stoichiometry:c171 : 1
m1055*m119368*0.1
nodelay
--
0
PMIFD: 16762830,1695551 The first depends on protein kinase R (PKR). This IFN-inducible kinase becomes activated following binding to cytoplasmic dsRNA that results in the phosphorylation of eukaryotic translation initiation factor (eIF2)-alpha
p52
p52
cso30:i:ME_UnknownActivation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c172 : 1
stoichiometry:c174 : 1
stoichiometry:c173 : 1
m72*m1055*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c175 : 1
stoichiometry:c176 : 1
stoichiometry:c177 : 1
m119368*m74*0.1
nodelay
--
0
PMID: 16762830 A second protein that is stimulated by dsRNA is 2¡ì?5¡ì oligoadenylate synthetase, an enzyme that activates the endoribonuclease RNase L through the synthesis of short oligoadenylates.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c178 : 1
stoichiometry:c179 : 1
stoichiometry:c180 : 1
m75*m76*0.1
nodelay
--
0
PMID: 16762830 A second protein that is stimulated by dsRNA is 2¡ì?5¡ì oligoadenylate synthetase, an enzyme that activates the endoribonuclease RNase L through the synthesis of short oligoadenylates
p55
p55
cso30:i:ME_Deubiquitination
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c181 : 1
stoichiometry:c182 : 1
stoichiometry:c183 : 1
m1585*m20*0.1
nodelay
--
0
PMID: 16762830 A20 bears both ubiquitin ligase and deubiquitinase activities that prevent prolonged TNF-induced NF-¦ÊB activation by firstly removing K63-linked RIP1 ubiquitin chains that are required for signaling and by secondly promoting K48-linked ubiquitin chains.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c184 : 1
stoichiometry:c185 : 1
m78*0.1
nodelay
--
0
PMID: 16762830 A20 bears both ubiquitin ligase and deubiquitinase activities that prevent prolonged TNF-induced NF-¦ÊB activation by firstly removing K63-linked RIP1 ubiquitin chains that are required for signaling and by secondly promoting K48-linked ubiquitin chains.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c125 : 1
stoichiometry:c186 : 1
stoichiometry:c187 : 1
m80*m18998*0.1
nodelay
--
0
PMID: 16762830,15710891,15767399,15710892 Whereas the adaptor Trif is an NS3-4A cleavage target in the TLR3 pathway,, NS3-4A disruption of RIG-I signaling occurs in a step between RIG-I and IKKvar epsilon, because the latter kinase rescues NS3-4A-mediated blockage
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c189 : 1
stoichiometry:c190 : 1
stoichiometry:c191 : 1
m80*m68199*0.1
nodelay
--
0
PMID: 16762830,16177806 Importantly, under such conditions of a productive HCV infection, Cardif is also cleaved by NS3-4A
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c17 : 1
stoichiometry:c18 : 1
m18*m183*0.1
nodelay
--
0
PMID: 16762830,12609980,14530355 First, Trif recruits tumor necrosis factor receptor (TNF-R) associated factor (TRAF)-6 by means of its N-terminal region
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c28 : 1
stoichiometry:c21 : 1
m19*m20*0.1
nodelay
--
0
PMID: 16762830,11734559, Second, Trif contains a C-terminal RIP homotypic interaction motif (RHIM; that interacts with the RHIM of both receptor interacting protein (RIP)-1 and RIP3 kinases that interacts with the RHIM of both receptor interacting protein (RIP)-1 and RIP3 kinases PMID: 16762830 RIP3 may inhibit NF-¦ÊB activation by destabilizing Trif-RIP1 interaction.
p8
p8
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c23 : 1
stoichiometry:c22 : 1
stoichiometry:c132 : 1
stoichiometry:c24 : 1
m22*m40*0.1
nodelay
--
0
PMID: 16762830,15064760,16115877 Whereas RIP1 transmits Trif-induced NF-¦ÊB activation, RIP3 appears to bear regulatory functions PMID: 16762830 Another molecule, TRAF1, which is a unique NF-¦ÊB-inducible member of the TRAF family that lacks an N-terminal RING finger, also inhibits Trif signaling to both IRF3 and NF-¦ÊB.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c26 : 1
stoichiometry:c25 : 1
stoichiometry:c27 : 1
m3825*m19*0.1
nodelay
--
0
PMID: 16762830,11734559, Second, Trif contains a C-terminal RIP homotypic interaction motif (RHIM; that interacts with the RHIM of both receptor interacting protein (RIP)-1 and RIP3 kinases that interacts with the RHIM of both receptor interacting protein (RIP)-1 and RIP3 kinases
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--